Alto Neuroscience, Inc.
NYSEANRO enters today's earnings release with one of the more charged positioning setups in small-cap biotech — short interest has nearly doubled in six weeks while the stock keeps climbing. The most striking feature of the setup is how aggressively short sellers have rebuilt positions into this rally. Short interest has risen 88% over the past month to 10.4% of the free float, a level…
ANRO short interest surges 37% in one day to 7.8% of float, marking a 48% weekly jump amid elevated bearish positioning.
ANRO enters today's earnings release with one of the more charged positioning setups in small-cap biotech — short interest has nearly doubled in six weeks while the stock keeps climbing. The most striking feature of…
Options traders have turned sharply bullish on ANRO just days before its May 21 earnings call. The put-call ratio crashed to 0.37 on May 18 — 2.17 standard deviations below its 20-day mean of 0.74. That's the most…
Snapshot as of 19 Aug 2026
ANRO enters its May 21 earnings event with a striking and sudden shift in options sentiment — one that stands in sharp contrast to the stock's recent price weakness and a track record of post-earnings declines. The…
ANRO reports its latest results today with options traders having shifted sharply toward protection in recent weeks — a stance that puts the options market well outside its recent comfort zone. The shift in options…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ANRO — free to start on ORTEX.
Sign up for free →Open ANRO on ORTEX